Month: May 2021

Herbs have been used in medicine for many years, and their powers are only becoming more recognised in the Western world. From infusions to decoctions and tinctures, there are many ways to introduce herbs into our daily lives. Plants and mushrooms have been used traditionally in many cultures for their healing qualities. Herbalists have been
0 Comments
Ocular signs and symptoms of thyroid eye disease (TED) often persist beyond the active phase of the condition, with many patients continuing to experience mental health issues and diminished quality of life, new research suggests. The autoimmune condition TED involves orbital inflammation with subsequent proptosis (eye bulging), diplopia, corneal exposure, vision changes, and potential blindness.
0 Comments
Primary endpoint of non-inferior immunogenicity versus the Phase 3 study adult comparator group was met No cases of COVID-19 observed after two doses of vaccine using the primary case definition, consistent with a vaccine efficacy of 100% Safety and tolerability generally consistent with Phase 3 COVE study in adults; no significant safety concerns identified Company
0 Comments
FDA Approves Truseltiq (infigratinib) for the Treatment of Cholangiocarcinoma PALO ALTO, Calif. and LUGANO, Switzerland, May 28, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), through its affiliate QED Therapeutics, Inc., and Helsinn Group today announced that the US Food and Drug Administration (FDA) has approved Truseltiq (infigratinib) under the accelerated approval program for
0 Comments
Global Wellness expert Deepak Chopra has told CNBC that he is “devastated” and “heartbroken” about the Covid-19 crisis currently gripping India, saying he feels the country could have managed the situation much better. Chopra, who was born and raised in New Delhi before continuing his medical training in the U.S., said he hopes lessons have
0 Comments
Another randomized trial has compared two common approaches to stenting complex and challenging left-main (LM) coronary bifurcation lesions, and this one showed little difference between the strategies on clinical outcomes at 1 year. Both types of intervention worked well, procedurally and in terms of symptoms, researchers said. But “stepwise, provisional stenting” used fewer stents and other
0 Comments
Putting ourselves into another’s shoes might seem simple to some, but for others it’s no walk in the park. Here, we explore the two ends of the empathy scale Possessing empathy is a significant human capability that allows us to connect with one another, as well as to recognise, understand, and share a range of
0 Comments
To mark World Vape Day, BAT has today published a comprehensive review of the scientific evidence for vaping products (e-cigarettes), their potential health effects and their role in Tobacco Harm Reduction. This review shows that, over the past decade, the number of people who incorrectly believe vaping is as harmful or more harmful than smoking
0 Comments
FDA Approves Pylarify (piflufolastat F 18) PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer May 27, 2021 — FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. With the approval of Pylarify, certain men with prostate
0 Comments
Reunions are on the horizon, but what is it about social bonds that makes them run so deep? Family means something different to all of us. For some, it’s nuclear, for others it’s blended, adopted, or chosen. Our friends also join us in our inner circles, standing with us through the good and bad –
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Gastrointestinal symptoms and chronic fatigue may persist months after the COVID-19 virus infection resolves, results of a recent cohort-controlled study suggest. About 5 months after SARS-CoV-2 infection, relative risks of loose stools, somatization, and chronic fatigue were increased by approximately two-
0 Comments
SER-109, an oral microbiome therapeutic, safely protects against Clostridioides difficile recurrence for up to 24 weeks, according to a recent phase 3 trial. Three days of treatment with purified Firmicutes spores reduced risk of recurrence by 54%, suggesting a sustained, clinically meaningful response, according to a multicenter study presented at this year’s Digestive Disease Week® (DDW). “Antibiotics targeted
0 Comments
May 29 2021 University of Virginia School of Medicine researchers have shed new light on how our brains develop, revealing that the very last step in cell division is crucial for the brain to reach its proper size and function. Noelle D. Dwyer, PhD, and her team have made new discoveries about brain development. Image
0 Comments
May is Mental Health Awareness Month. Over the next few weeks, OncoLink will feature blogs about common mental health challenges faced by cancer patients, caregivers, and healthcare professionals. Please remember, if you are in crisis, help is available. National Suicide Prevention Lifeline 800-273-8255 National Alliance on Mental Health (NAMI) Helpline 800-950-6264 A caregiver is someone
0 Comments
ROCKVILLE, Md.–(BUSINESS WIRE)–May 26, 2021– GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that clinicians at Washington University School of Medicine in St. Louis have dosed the first patient in an investigator-sponsored trial (IST) evaluating uproleselan as a prophylactic agent to reduce gastrointestinal (GI) toxicities associated with high-dose melphalan in autologous hematopoietic cell transplantation (auto-HCT) for multiple myeloma (MM). Dr. Keith Stockerl-Goldstein, M.D., Professor
0 Comments
FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell
0 Comments
WASHINGTON — President Biden released a proposed $5 trillion budget Friday for fiscal year 2022, promising to “reinvest in education, research, public health, and other foundations of our country’s strength.” The proposal contained a variety of healthcare-related initiatives, including: $97.5 billion to improve access to Department of Veterans Affairs (VA) healthcare, including increases in funding
0 Comments